The second phase of Kilroy Realty's sprawling Oyster Point life sciences campus in South San Francisco is climbing uphill in a bid to fill space as the lab leasing market languishes. Olema Pharmaceuticals is among the tenants, signing a 38K SF, seven-year lease in Phase 2 in the second quarter. We are optimistic by the overall level and quality of life science demand in the market,” Aman told investors. Life sciences tenants made up 19% of Kilroy’s portfolio by rent in the second quarter and 17% by square footage in both lab and office space. Overall, Kilroy’s stabilized portfolio was 77% occupied and 81.5% leased at the end of the second quarter, down from 80.8% and 83.5%, respectively.